Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2012
03/29/2012US20120077865 Methods for treating hypercholesterolemia
03/29/2012US20120077847 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077829 Parenteral solutions containing metolazone
03/29/2012US20120077823 Controlled release systems of pluribioactive antifungal drugs and applications thereof
03/29/2012US20120077822 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
03/29/2012US20120077808 Niacin Mimetics, and Methods of Use Thereof
03/29/2012US20120077807 Niacin mimetics, and methods of use thereof
03/29/2012US20120077749 Biologically Active Peptides
03/29/2012US20120076868 Cross-linked bioactive hydrogel matrices
03/29/2012US20120076799 Antagonists of pcsk9
03/29/2012US20120076797 Modulation of kit signaling and hematopoietic cell development by IL-4 receptor modulation
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076771 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials
03/29/2012US20120076760 Compositions and methods of vascular injury repair cross-reference to related applications
03/29/2012US20120076750 Fibrin based glue with functionalized hydrophilic polymer protein binding agent
03/29/2012US20120076749 Modified Blood Factors Comprising a Low Degree of Water Soluble Polymer
03/29/2012US20120076731 Lymphedema associated genes and model
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012CA2813049A1 Modified compstatin with improved stability and binding properties
03/28/2012EP2434013A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof
03/28/2012EP2433940A1 Spiroimidazolone derivative
03/28/2012EP2433630A1 Self-emulsifying composition of 3 fatty acid
03/28/2012EP2260048B1 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest
03/28/2012EP1272197B2 Combination of lecithin with ascorbic acid
03/28/2012EP1117684B1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
03/28/2012CN1939430B Dispersing tablets for clearing heat,purging fire and detoxifying
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395557A Kinase inhibitor compounds
03/28/2012CN102395354A Microneedle array using porous substrate and process for producing same
03/28/2012CN102391360A Small peptide capable of resisting thrombosis and platelet aggregation
03/28/2012CN102391336A Compound and preparation method and use thereof
03/28/2012CN102391283A Clopidogrel hydrogen sulfate compound and preparation method thereof
03/28/2012CN102391192A Preparation method and application of shikimic acid ligustrazine
03/28/2012CN102389592A Cryoprecipitation blood coagulation factor preparation instrument
03/28/2012CN102389564A Compositions for use in treating myelodysplastic syndrome
03/28/2012CN102389527A Chinese medicinal composition for repairing human-body internal organs
03/28/2012CN102389511A Anti-radiation Chinese medicine preparation and preparation method thereof
03/28/2012CN102389470A Traditional Chinese medicinal composition for promoting blood circulation and removing obstructions in channels
03/28/2012CN102389442A Lumbricus extract possessing antithrombotic effect
03/28/2012CN102389436A Medicinal composition for resisting platelet aggregation
03/28/2012CN102389245A Formula of health care medicine pillow for detoxifying and health-promoting
03/28/2012CN102388812A Beef cattle nose ring
03/28/2012CN102058863B Chinese medicinal composition for eliminating body edema
03/28/2012CN102049035B Starch polysaccharide-iron compound preparation
03/28/2012CN102028816B Chinese herbal medicinal compound preparation for treating hemorrhage disease of grass carp
03/28/2012CN102028757B Processing method of mulberry composite extract
03/28/2012CN102018736B Natural indigo decoction piece and preparation method thereof
03/28/2012CN102008506B Formula of injection for convergence and hemostasis of internal hemorrhoid hemorrhage and preparation method thereof
03/28/2012CN101973925B 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof
03/28/2012CN101632724B Application of polygonum orientale and erigeron breviscapus composition in preparing medicaments for treating cerebrovascular disease and correlative diseases
03/28/2012CN101606954B Method for extracting and purifying flavonoid substance from selaginella tamariscina
03/28/2012CN101543512B Method for producing dry earthworm powder
03/28/2012CN101318994B Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof
03/28/2012CN101270152B Peptide medicament series for accelerating medulla hematopoiesis cell proliferation
03/28/2012CN101264320B Oxygen-carrying blood substitute preparations
03/27/2012CA2489862C Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/27/2012CA2431487C Oligo or polyalkylene glycol-coupled thrombin inhibitors
03/27/2012CA2406179C Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors
03/22/2012WO2012036152A1 High purity heparin and production method therefor
03/22/2012WO2012034519A1 Tannin extract of sanguisorba officinalis l. and preparation method and use thereof
03/22/2012WO2012034188A1 Peptide inhibitors of cd40l signaling and uses therefor
03/22/2012US20120073002 Prevention and treatment of blood coagulation-related disases
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071519 CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071461 Substituted Benzamide Compounds
03/22/2012US20120071433 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives
03/22/2012US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis
03/22/2012US20120071406 Modified vegf-a with improved angiogenic properties
03/22/2012US20120071403 Methods for Treating Type 2 Diabetes in Patients Resistant to Previous Treatment with other Anti-Diabetic Drugs Employing an SGLT2 Inhibitor and Compositions Thereof
03/22/2012US20120070520 Composition containing a bean extract for improving blood circulation and increasing vascular health
03/22/2012US20120070513 Method and Composition for Treating Diabetic Ketoacidosis
03/22/2012US20120070483 Multi-Functional Biocompatible Coatings for Intravascular Devices
03/22/2012US20120070477 Dry powder fibrin sealant
03/22/2012US20120070472 Chronotherapeutic compositions and methods of their use
03/22/2012US20120070470 Hemostatic compositions, devices, and methods
03/22/2012US20120070441 Extracellular yaluronidase from streptomyces koganeiensis
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070434 Antibodies containing therapeutic tpo/epo mimetic peptides
03/22/2012US20120070390 Topical drug delivery system with dual carriers
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012CA2811186A1 High purity heparin and production method therefor
03/21/2012EP2431390A1 Compositions and methods for modulating hemostasis
03/21/2012EP2431389A1 Compositions and methods for modulating hemostasis
03/21/2012EP2431359A1 Process for preparing diaminophenothiazinium compounds
03/21/2012EP1732932B1 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
03/21/2012EP1688488B9 Bispecific antibody substituting for factor viii
03/21/2012EP1488808B1 Remedies for glomerular diseases
03/21/2012EP1436624B1 A method of diagnosis and treatment and agents useful for same
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102382747A Chinese herbal health care wine and manufacturing method thereof
03/21/2012CN102382204A Low-molecular-weight polysaccharide sulfate and preparation method and application thereof
03/21/2012CN102382192A Hypoallergenic recombinant immunotoxin, and preparation method and application thereof
03/21/2012CN102382169A Argatroban single stereoisomer separation method and polymorph
03/21/2012CN102382156A Preparation method of rehmannioside D standard substance
03/21/2012CN102382121A Ginkgolide derivative and application thereof to pharmacy
03/21/2012CN102382113A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 671